BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31115856)

  • 1. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
    Sakaguchi R; Kataoka M; Kanao S; Miyake KK; Nakamoto Y; Sugie T; Toi M; Mikami Y; Togashi K
    Ann Nucl Med; 2019 Aug; 33(8):570-578. PubMed ID: 31115856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
    Sasada S; Shiroma N; Goda N; Kajitani K; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
    Breast Cancer Res Treat; 2019 Oct; 177(3):651-657. PubMed ID: 31267329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
    Masumoto N; Kadoya T; Sasada S; Emi A; Arihiro K; Okada M
    Breast Cancer Res Treat; 2018 Sep; 171(2):315-323. PubMed ID: 29779072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
    Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
    Eur J Surg Oncol; 2018 Apr; 44(4):444-448. PubMed ID: 29396328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
    Sasada S; Kimura Y; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
    Eur J Surg Oncol; 2021 Jul; 47(7):1588-1592. PubMed ID: 33685728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
    Sueoka S; Sasada S; Masumoto N; Emi A; Kadoya T; Okada M
    Breast Cancer Res Treat; 2021 May; 187(1):125-133. PubMed ID: 33484374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
    Nishimatsu K; Nakamoto Y; Miyake KK; Ishimori T; Kanao S; Toi M; Togashi K
    Eur J Radiol; 2017 May; 90():138-145. PubMed ID: 28583624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of dedicated breast positron emission tomography.
    Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S
    Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
    Satoh Y; Motosugi U; Imai M; Onishi H
    Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.
    Hathi DK; Li W; Seo Y; Flavell RR; Kornak J; Franc BL; Joe BN; Esserman LJ; Hylton NM; Jones EF
    Sci Rep; 2020 Dec; 10(1):21930. PubMed ID: 33318514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of dedicated breast PET for the assessment of residual tumor after neoadjuvant chemotherapy.
    Koyasu H; Goshima S; Noda Y; Nishibori H; Takeuchi M; Matsunaga K; Yamada T; Matsuo M
    Jpn J Radiol; 2019 Jan; 37(1):81-87. PubMed ID: 30392134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
    Tokuda Y; Yanagawa M; Fujita Y; Honma K; Tanei T; Shimoda M; Miyake T; Naoi Y; Kim SJ; Shimazu K; Hamada S; Tomiyama N
    Breast Cancer Res Treat; 2021 Jul; 188(1):107-115. PubMed ID: 33730265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of radioactivity outside the field of view on image quality of dedicated breast positron emission tomography: preliminary phantom and clinical studies.
    Satoh Y; Imai M; Ikegawa C; Hirata K; Abo N; Kusuzaki M; Oyama-Manabe N; Onishi H
    Ann Nucl Med; 2022 Dec; 36(12):1010-1018. PubMed ID: 36207497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected Abnormal Uptake in the Breasts at Dedicated Breast PET: Incidentally Detected Small Cancers or Nonmalignant Features?
    Satoh Y; Motosugi U; Omiya Y; Onishi H
    AJR Am J Roentgenol; 2019 Feb; 212(2):443-449. PubMed ID: 30476450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
    Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Texture Analysis in the Diagnosis of Primary Breast Cancer: Comparison of High-Resolution Dedicated Breast Positron Emission Tomography (dbPET) and Whole-Body PET/CT.
    Satoh Y; Hirata K; Tamada D; Funayama S; Onishi H
    Front Med (Lausanne); 2020; 7():603303. PubMed ID: 33425949
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
    Arslan E; Çermik TF; Trabulus FDC; Talu ECK; Başaran Ş
    Nucl Med Commun; 2018 Jul; 39(7):680-690. PubMed ID: 29893750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Texture analysis of high-resolution dedicated breast
    Moscoso A; Ruibal Á; Domínguez-Prado I; Fernández-Ferreiro A; Herranz M; Albaina L; Argibay S; Silva-Rodríguez J; Pardo-Montero J; Aguiar P
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):196-206. PubMed ID: 28936601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
    Teixeira SC; Rebolleda JF; Koolen BB; Wesseling J; Jurado RS; Stokkel MP; Del Puig Cózar Santiago M; van der Noort V; Rutgers EJ; Valdés Olmos RA
    AJR Am J Roentgenol; 2016 Jun; 206(6):1307-14. PubMed ID: 27058014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.